Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Lymphoma 447Precursor Cell Lymphoblastic Leukemia-Lymphoma 413Lymphoma, Large B-Cell, Diffuse 348Lymphoma, Non-Hodgkin 317Leukemia, Lymphocytic, Chronic, B-Cell 286Leukemia 260Lymphoma, Follicular 241Burkitt Lymphoma 217Lymphoma, Mantle-Cell 202Hodgkin Disease 193Leukemia, Myeloid, Acute 190Myelodysplastic Syndromes 172Lymphoma, B-Cell, Marginal Zone 142Multiple Myeloma 116Lymphoma, Large-Cell, Immunoblastic 116Lymphoma, B-Cell 103Recurrence 100Leukemia, Myelogenous, Chronic, BCR-ABL Positive 76Myeloproliferative Disorders 75Leukemia, Myeloid, Chronic-Phase 73Dendritic Cell Sarcoma, Interdigitating 73Leukemia, Myeloid, Accelerated Phase 72Leukemia, Myelomonocytic, Chronic 67Lymphoma, Large-Cell, Anaplastic 65Waldenstrom Macroglobulinemia 63Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 63Neoplasms, Plasma Cell 59Blast Crisis 58Primary Myelofibrosis 54Congenital Abnormalities 52

Interventions

fludarabine phosphate 1Whole-Body Irradiation 1Thiotepa 1Melphalan 1Cyclophosphamide 1Clinical Trials, Phase I as Topic 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metabolism, Inborn Errors × Cyclophosphamide × Lymphoid × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡